Bayer Q2 profits jump on new drugs, lower charges (Update)
German drug and chemicals company Bayer AG says net profit rose 75 percent in the second quarter thanks to lower one-time charges and strong sales of new products including anti-clotting drug Xarelto and cancer drug Stivarga.
Jul 31, 2013
0
0